MED
Medifast Stock Analysis
AI Rating
- Quality9/10
- Growth↓ 1/10
- Value↑ 5/10
MED Growth
- Revenue Y/Y↓ -35.96%
- EPS Y/Y↓ -994.74%
- FCF Y/Y↓ -92.66%
MED Profitability
- Gross margin ↑ 71.30%
- EPS margin↓ -4.80%
- ROIC 5Y↓ 57.88%
MED Risk
- Debt / Equity↓ 0.1
- Debt / FCF↓ 0.0
- Interest coverage↑ 999.0
Medifast stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.